Syantra
Calgary, CA · 3 known investors
Find your way into Syantra
213 people in our graph share verified history with the Syantra team — schools, employers, funds. One of them is your warm intro.
Rami Rahalunlockedknows Randy Moore · together at McMaster University (overlapped)
knows the team · via University of Calgary
×10knows the team · via McMaster University
Syantra develops the patent-pending Onco-ID platform for early cancer detection, using a biomarker and drug target discovery technology to support oncologists and pharmaceutical scientists in creating personalized, precision cancer treatments. Founded from research at the University of Calgary, it serves the oncology diagnostics and precision medicine market.
Founders & leadership
TR
Tina RinkerCo-founder
KF
Ken FuhCo-founder
RM
Randy MooreinCo-founderRandy Moore is a Professor of Surgery at the University of Calgary with over three decades of healthcare experience, including leadership roles as Chief Medical Officer at ViTAA Medical Solutions and Medical Director at Syantra, where he brings expertise in vascular surgery to the development of precision medicine solutions.
BS
Bob ShepherdCo-founder
Investors · 3
Funding
SEC filings, press & company announcements$3.6M disclosed across 1 round · 2024
- $3.6MSeries A-1Sep 2024 · 5 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 4
by search overlap
Natera7 shared keywordsNatera develops genetic tests and diagnostics using cell-free DNA technology to detect diseases including cancers, genetic disorders, and transplant-related conditions. The company serves patients, physicians, and healthcare systems across oncology, women's health, and organ health.
Foxbusiness6 shared keywordsFOX Business Network is a financial news channel that delivers real-time business and market information across multiple platforms. The network serves investors and business audiences interested in news affecting both retail and institutional markets.
Outcomes4Me5 shared keywordsOutcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information. The platform serves cancer patients directly by offering decision support tools and health data management to improve treatment access and outcomes.
Labcorp5 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Companies competing with Syantra for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Syantra do?
- Syantra develops the patent-pending Onco-ID platform for early cancer detection, using a biomarker and drug target discovery technology to support oncologists and pharmaceutical scientists in creating personalized, precision cancer treatments. Founded from research at the University of Calgary, it serves the oncology diagnostics and precision medicine market.
- Who founded Syantra?
- Syantra was founded by Tina Rinker, Ken Fuh, Randy Moore, Bob Shepherd.
- Who are Syantra's investors?
- Syantra's investors include The 51 Ventures, Thin Air Labs, UCeed Funds.
- How much funding has Syantra raised?
- Syantra has disclosed $3.6M raised across 1 round.
- Where is Syantra headquartered?
- Syantra is headquartered in Calgary, CA.